![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEBI | |
Chemical and physical data | |
Formula | C20H16ClN3O2 |
Molar mass | 365.82 g·mol−1 |
3D model (JSmol) | |
| |
|
CPI-0610 is a drug which acts as a BET inhibitor, mainly acting at the BRD2 and BRD4 subtypes. It has potential applications in the treatment of various forms of cancer.[1][2][3][4]